Plasma Kisspeptin-54 levels in gastric cancer patients.

Ergen A., canbay E., bugra D., Zeybek U., Yamaner S., Bulut T.

International journal of surgery (London, England), vol.10, no.9, pp.551-4, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 9
  • Publication Date: 2012
  • Doi Number: 10.1016/j.ijsu.2012.08.014
  • Journal Name: International journal of surgery (London, England)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.551-4
  • Keywords: Kisspeptin-54, Gastric cancer, Enzyme immunoassay, Diagnostic parameters, METASTASIS SUPPRESSOR GENE, PANCREATIC-CANCER, EXPRESSION, KISS-1, CARCINOMA, RECEPTOR
  • Istanbul University Affiliated: Yes

Abstract

Background: Kisspeptin (Kisspeptin-54; KP-54) is a 54-amino acid peptide was originally known as metastin that was implicated in suppression of tumor metastasis and circulating kisspeptin has been proposed as a tumor marker for numerous cancers in humans. However, the plasma level of KP-54 in gastric cancer (GC) remains undetermined.